Authors


Kristi Rosa

Latest:

FDA Approves Relatlimab Plus Nivolumab for Unresectable or Metastatic Melanoma

The FDA has approved the fixed-dose combination of relatlimab plus nivolumab for the treatment of adult and pediatric patients who are 12 years of age or older and who have unresectable or metastatic melanoma.



Jerry Shapiro, MD

Latest:

A Hairy Q&A With Jerry Shapiro, MD

The hair guru explains how he opened up the first dermatology practice dedicated to hair, pearls from his session, innovative therapies, and research he has recently submitted.


Michael Joyce, CFA, CFP

Latest:

Impacts of the Inflation Reduction Act on Doctors

How will new federal law affect lives and wallets of physicians?


Tony Hagen

Latest:

Biosimilars for Humira Are on Their Way

In 2023 as many as 11 biosimilars to Humira are headed for the US market.


Amy S. Paller, MS, MD

Latest:

Amy Paller, MD: Reviewing Top Insights for Clinical Practice From ESPD

Paller discusses her SPD 2024 lecture, "Updates from ISSVA, ESPD, and SID: What You Missed that Could Change Your Practice."



Joslyn Kirby, MD

Latest:

Joslyn Kirby, MD, Shares OTC Product Benefits and HS Procedural Pearls

Kirby presented at both Fall Clinical and the Inflammatory Disease Summit in Las Vegas.



Nina M. D’Amiano, BA

Latest:

Best Practices for Identifying and Managing Granulomatous Dermatitis

The clinical and histologic subtypes encompassed by granulomatous dermatitis include palisaded neutrophilic granulomatous dermatitis and interstitial granulomatous dermatitis. This review compares the features of each cutaneous eruption.


Ami Greene, MD

Latest:

Ami Greene, MD: Tools and Tricks for Beginner to Intermediate Dermoscopy

Ami Greene, MD, discusses her beginner and intermediate SDPA fall conference sessions on dermoscopy.


Lois Levine, Correspondent

Latest:

Countdown to RAVE!

Three distinct congresses known as RAVE (Revolutionizing Atopic Dermatitis, Alopecia Areata, and Vitiligo) will be held June 8-10, in Chicago, Illinois.



Rajeev Ronanki

Latest:

3 Approaches to Creating a Connected Care Future

By integrating capabilities and services, we can create health experiences that are much more than the sum of their parts.



Jonathan Lai, BA

Latest:

Best Practices for Identifying and Managing Granulomatous Dermatitis

The clinical and histologic subtypes encompassed by granulomatous dermatitis include palisaded neutrophilic granulomatous dermatitis and interstitial granulomatous dermatitis. This review compares the features of each cutaneous eruption.


Keith Loria

Latest:

Oncology Pharmacists Are Crucial in Skin Cancer Management

From explaining how medications work and should be taken to reviewing potential adverse effects and financial details, pharmacists are crucial resources for patients undergoing treatment for skin cancer.


Terry Ciesla

Latest:

4 tips to curbing rising costs and staffing shortfalls

Medical networks and smaller practices alike are facing spiraling inflation costs and staffing shortfalls due to waves of COVID cases that are impacting physicians, staff, and management.


Heidi Prather, MD, FAAD

Latest:

What's New in Aesthetics With Heidi Prather, MD

Hyaluronic acid fillers and biostimulators were a couple of Prather's recent favorite aesthetic advancements.


Lisa Weiss, MMSc, PA-C

Latest:

Balancing Patient Needs and Telemedicine Considerations

Panelists discuss how health care providers must balance the convenience and accessibility of telemedicine with individual patient needs and clinical considerations when delivering dermatological care.


Jacqueline Watchmaker, MD, FAAD

Latest:

Jacqueline Watchmaker MD, FAAD, Discusses the Innovative InterFuse Treatment Cream for Aging Skin

“I think some key things that stand out to me are that it's safe, effective, backed by rigorous clinical data, and has very high patient satisfaction,” Watchmaker said about the new product.


Jim Keller, MD

Latest:

Considering consumerism in health care

Patients’ ability to choose can affect your practice.


Amy McMichael, MD

Latest:

Sun Protection in Patients With Skin of Color

An expert in dermatology shares her thoughts at AAD on the sun protection needs in her patients with skin of color; highlighting the role of the Fitzpatrick skin type scale and compounds such as vitamin E and antioxidants.


Cyaandi R. Dove, DPM

Latest:

Closing the Wound Care Gap: Addressing Disparities in Amputations and Limb Preservation

Recent technological advancements such as the development and use of human cellular and tissue-based products and advanced skin substitutes have transformed limb preservation.


Jashin Wu, MD

Latest:

Plaque Psoriasis Management: Future Directions in Care

Closing out their discussion on the management of plaque psoriasis, panelists share their excitement for future directions in care.


Richard Payerchin

Latest:

Federal Trade Commission Votes to Ban Noncompete Clauses Between Employers and Workers

In online discussion April 23, commissioners cited health care specifically among their reasons for supporting the ban.


Eric Simpson, MD, MCR

Latest:

Eric Simpson, MD, Discusses Recently Announced EADV Data On Tapinarof Cream for AD Down to 2 Years

New data from ADORING 1 and ADORING 2 show a rapid reduction in pruritus relief as early as 24 hours after the first application.


Paul Yamauchi, MD, PhD

Latest:

New Research Confirms Effective Therapy for Nail Psoriasis

Nail psoriasis affects 50% of plaque psoriasis patients, making effective treatments crucial.


Erin Boh, MD

Latest:

Case 2 Presentation: 58-Year-Old Woman With GPP

Erin Boh, MD, emphasizes the importance of patient empowerment and physician education surrounding the management of GPP.


Alexandra Kimball, MD

Latest:

Late-Breaking Data: Lutikizumab Shows Positive Results in Difficult-to-Treat HS After Failed TNF Therapy

Alexandra Kimball, MD, FAAD, reviews late-breaking data at AAD on lutikizumab for hidradenitis suppurativa.

© 2025 MJH Life Sciences

All rights reserved.